Ilex Medical Financials
ILX Stock | 7,859 156.00 2.03% |
Ilex |
Understanding current and past Ilex Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Ilex Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Ilex Medical's assets may result in an increase in income on the income statement.
Please note, the presentation of Ilex Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Ilex Medical's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Ilex Medical's management manipulating its earnings.
Ilex Medical Stock Summary
Ilex Medical competes with Danel, Rami Levi, Hilan, Fox Wizel, and Tadiran Hldg. Ilex Medical Ltd engages in marketing, selling, and supporting equipment, disposables, and reagents for laboratories and healthcare establishments in Israel and South Africa. Ilex Medical Ltd was founded in 1977 and is based in Petah Tikva, Israel. Ilex Medical is traded on Tel Aviv Stock Exchange in Israel.Instrument | Israel Stock View All |
Exchange | Tel Aviv Stock Exchange |
ISIN | IL0010807530 |
Business Address | Kodak Building, Petah |
Sector | Health Care Providers & Services |
Industry | Health Care |
Benchmark | Dow Jones Industrial |
Website | www.ilexmedical.com |
Phone | 972 3 938 5501 |
You should never invest in Ilex Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Ilex Stock, because this is throwing your money away. Analyzing the key information contained in Ilex Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Ilex Medical Key Financial Ratios
Ilex Medical's financial ratios allow both analysts and investors to convert raw data from Ilex Medical's financial statements into concise, actionable information that can be used to evaluate the performance of Ilex Medical over time and compare it to other companies across industries.Ilex Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Ilex Medical's current stock value. Our valuation model uses many indicators to compare Ilex Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Ilex Medical competition to find correlations between indicators driving Ilex Medical's intrinsic value. More Info.Ilex Medical is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.61 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Ilex Medical is roughly 1.65 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Ilex Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Ilex Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Ilex Medical Systematic Risk
Ilex Medical's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Ilex Medical volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was ten with a total number of output elements of fifty-one. The Beta measures systematic risk based on how returns on Ilex Medical correlated with the market. If Beta is less than 0 Ilex Medical generally moves in the opposite direction as compared to the market. If Ilex Medical Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Ilex Medical is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Ilex Medical is generally in the same direction as the market. If Beta > 1 Ilex Medical moves generally in the same direction as, but more than the movement of the benchmark.
Ilex Medical Thematic Clasifications
Ilex Medical is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
Drugs | View |
Ilex Medical November 30, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Ilex Medical help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Ilex Medical. We use our internally-developed statistical techniques to arrive at the intrinsic value of Ilex Medical based on widely used predictive technical indicators. In general, we focus on analyzing Ilex Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Ilex Medical's daily price indicators and compare them against related drivers.
Downside Deviation | 2.15 | |||
Information Ratio | 0.036 | |||
Maximum Drawdown | 8.75 | |||
Value At Risk | (4.07) | |||
Potential Upside | 4.21 |
Complementary Tools for Ilex Stock analysis
When running Ilex Medical's price analysis, check to measure Ilex Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ilex Medical is operating at the current time. Most of Ilex Medical's value examination focuses on studying past and present price action to predict the probability of Ilex Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ilex Medical's price. Additionally, you may evaluate how the addition of Ilex Medical to your portfolios can decrease your overall portfolio volatility.
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |